Alexza Shares Sink as the FDA Denies Its Antipsychotic Drug
Alexza Pharmaceuticals shares are tanking in early trading after the company announced today that the U.S. Food and Drug Administration has not approved its AZ-004, an antipsychotic inhaled drug for treating agitation in schizo…